The pediatric asymptomatic SARS-CoV-2 IgG seropositivity in the Turkish Republic of Northern Cyprus
Yıl: 2022 Cilt: 64 Sayı: 1 Sayfa Aralığı: 179 - 185 Metin Dili: İngilizce DOI: 10.24953/turkjped.2021.1330 İndeks Tarihi: 15-12-2022
The pediatric asymptomatic SARS-CoV-2 IgG seropositivity in the Turkish Republic of Northern Cyprus
Öz: Background. While children were initially thought to have serious contributions to the coronavirus disease 2019 (COVID-19) transmission, recent studies suggest otherwise. However, the possible effect of asymptomatic pediatric spread still has not yet received enough attention. The aim of our study was to estimate asymptomatic infection rates among children in the Turkish Republic of Northern Cyprus, by using pediatric patients admitted to a university hospital without any COVID-19-associated symptoms. Methods. Blood samples collected from 80 pediatric patients with no symptoms and history of COVID-19 infection, who were admitted to a university hospital between September 2020 and January 2021, were included in the retrospective study. Isolated serum samples were tested by Dia.Pro SARS-CoV-2 IgG ELISA assays. Results. The patient group included 40 (50%) male and 40 (50%) female patients. The average age of children was 7.6 ± 4.0 years, with min-max ages ranging from 2 to 15 years. Among the 80 patients tested, only one (1.3%) was detected positive by the Dia.Pro IgG ELISA kit. Conclusions. The asymptomatic seropositivity reported in our study suggests the use of randomly performed serologic tests to monitor SARS-CoV-2 infection among the pediatric population in schools that would contribute to the public health fight against COVID-19.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Kısa Bildiri Erişim Türü: Erişime Açık
- 1. Sultanoglu N, Baddal B, Suer K, Sanlidag T. Current situation of COVID-19 in northern Cyprus. East Mediterr Health J 2020; 26: 641-645. https://doi.org/10.26719/emhj.20.070
- 2. Turkish Republic of Norhtern Cyprus, Ministry of Health. Available at: https://saglik.gov.ct.tr/COVID- 19-GENEL-DURUM (Accessed on December 28, 2021).
- 3. Viner RM, Russell SJ, Croker H, et al. School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review. The Lancet Child Adolesc Health 2020; 4: 397- 404. https://doi.org/10.1016/S2352-4642(20)30095-X
- 4. Li X, Xu W, Dozier M, He Y, Kirolos A, Theodoratou E. The role of children in transmission of SARSCoV- 2: a rapid review. J Glob Health 2020; 10: 011101. https://doi.org/10.7189/jogh.10.011101
- 5. Hyde Z. Difference in SARS-CoV-2 attack rate between children and adults may reflect bias. Clin Infect Dis 2022; 74: 152-155. https://doi.org/10.1093/cid/ciab183
- 6. Mensah AA, Sinnathamby M, Zaidi A, et al. SARSCoV- 2 infections in children following the full re-opening of schools and the impact of national lockdown: prospective, national observational cohort surveillance, July-December 2020, England. J Infect 2021; 82: 67-74. https://doi.org/10.1016/j.jinf.2021.02.022
- 7. Ratmann O, Bhatt S, Flaxman S. Implications of a highly transmissible variant of SARS-CoV-2 for children. Arch Dis Child 2021; 106: e37. https://doi.org/10.1136/archdischild-2021-321903
- 8. Williams PCM, Howard-Jones AR, Hsu P, et al. SARSCoV- 2 in children: spectrum of disease, transmission and immunopathological underpinnings. Pathology 2020; 52: 801-808. https://doi.org/10.1016/j.pathol.2020.08.001
- 9. Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection. Ann Internl Med 2021; 174: 286-287. https://doi.org/10.7326/L20-1280
- 10. Lauring AS, Hodcroft EB. Genetic variants of SARSCoV- 2 - What do they mean? JAMA 2021; 325: 529- 531. https://doi.org/10.1001/jama.2020.27124
- 11. KKTC İstatistik Kurumu. KKTC Nüfus Sayımı 2011. Available at: http://www.stat.gov.ct.tr/nufus2011. aspx (Accessed on December 28, 2021)
- 12. Al-Jighefee HT, Yassine HM, Nasrallah GK. Evaluation of antibody response in symptomatic and asymptomatic covid-19 patients and diagnostic assessment of new IgM/IgG elisa kits. Pathogens 2021; 10: 161. https://doi.org/10.3390/pathogens10020161
- 13. Cramer A, Goodman N, Cross T, Gant V, Dziadzio M. Analytical evaluation and critical appraisal of early commercial SARS-CoV-2 immunoassays for routine use in a diagnostic laboratory. Br J Biomed Sci 2021; 78: 141-146. https://doi.org/10.1080/09674845.2020.1864108
- 14. Rehman S, Majeed T, Ansari MA, Al-Suhaimi EA. Syndrome resembling Kawasaki disease in COVID-19 asymptomatic children. J Infect Public Health 2020; 13: 1830-1832. https://doi.org/10.1016/j.jiph.2020.08.003
- 15. Iesa MAM, Osman MEM, Hassan MA, et al. SARSCoV- 2 and Plasmodium falciparum common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt. New Microbes New Infect 2020; 38: 100817. https://doi.org/10.1016/j.nmni.2020.100817
- 16. Rostami A, Sepidarkish M, Leeflang MMG, et al. SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis. Clin Microbiol Infect 2021; 27: 331-340. https://doi.org/10.1016/j.cmi.2020.10.020
- 17. Viner RM, Ward JL, Hudson LD, et al. Systematic review of reviews of symptoms and signs of COVID-19 in children and adolescents. Arch Dis Child 2021; 106: 802-807. https://doi.org/10.1136/archdischild-2020-320972
- 18. Li Y, He Q, Yu R, et al. Highlighted prospects of an IgM/IgG antibodies test in identifying individuals with asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Arch Pathol Lab Med 2021; 145: 39-45. https://doi.org/10.5858/arpa.2020-0310-SA
- 19. Nuccetelli M, Pieri M, Gisone F, Bernardini S. Combined anti-SARS-CoV-2 IgA, IgG, and IgM detection as a better strategy to prevent second infection spreading waves. Imunol Invest 2020; 1-13. https://doi.org/10.1080/08820139.2020.1823407
- 20. Machado BAS, Hodel KVS, Barbosa-Júnior VG, Soares MBP, Badaró R. The main molecular and serological methods for diagnosing covid-19: an overview based on the literature. Viruses 2020; 13: 40. https://doi.org/10.3390/v13010040
- 21. La Marca A, Capuzzo M, Paglia T, Roli L, Trenti T, Nelson SM. Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays. Reprod Biomed Online 2020; 41: 483-499. https://doi.org/10.1016/j.rbmo.2020.06.001
| APA | Gazi U, ARIKAN A, Ruh E, sanlidag b, dalkan c, beyitler i, süer k, çakır n, SAYAN M, ŞANLIDAĞ T (2022). The pediatric asymptomatic SARS-CoV-2 IgG seropositivity in the Turkish Republic of Northern Cyprus. , 179 - 185. 10.24953/turkjped.2021.1330 |
| Chicago | Gazi Umut,ARIKAN AYSE,Ruh Emrah,sanlidag burcin,dalkan ceyhun,beyitler ilke,süer kaya,çakır nedim,SAYAN MURAT,ŞANLIDAĞ Tamer The pediatric asymptomatic SARS-CoV-2 IgG seropositivity in the Turkish Republic of Northern Cyprus. (2022): 179 - 185. 10.24953/turkjped.2021.1330 |
| MLA | Gazi Umut,ARIKAN AYSE,Ruh Emrah,sanlidag burcin,dalkan ceyhun,beyitler ilke,süer kaya,çakır nedim,SAYAN MURAT,ŞANLIDAĞ Tamer The pediatric asymptomatic SARS-CoV-2 IgG seropositivity in the Turkish Republic of Northern Cyprus. , 2022, ss.179 - 185. 10.24953/turkjped.2021.1330 |
| AMA | Gazi U,ARIKAN A,Ruh E,sanlidag b,dalkan c,beyitler i,süer k,çakır n,SAYAN M,ŞANLIDAĞ T The pediatric asymptomatic SARS-CoV-2 IgG seropositivity in the Turkish Republic of Northern Cyprus. . 2022; 179 - 185. 10.24953/turkjped.2021.1330 |
| Vancouver | Gazi U,ARIKAN A,Ruh E,sanlidag b,dalkan c,beyitler i,süer k,çakır n,SAYAN M,ŞANLIDAĞ T The pediatric asymptomatic SARS-CoV-2 IgG seropositivity in the Turkish Republic of Northern Cyprus. . 2022; 179 - 185. 10.24953/turkjped.2021.1330 |
| IEEE | Gazi U,ARIKAN A,Ruh E,sanlidag b,dalkan c,beyitler i,süer k,çakır n,SAYAN M,ŞANLIDAĞ T "The pediatric asymptomatic SARS-CoV-2 IgG seropositivity in the Turkish Republic of Northern Cyprus." , ss.179 - 185, 2022. 10.24953/turkjped.2021.1330 |
| ISNAD | Gazi, Umut vd. "The pediatric asymptomatic SARS-CoV-2 IgG seropositivity in the Turkish Republic of Northern Cyprus". (2022), 179-185. https://doi.org/10.24953/turkjped.2021.1330 |
| APA | Gazi U, ARIKAN A, Ruh E, sanlidag b, dalkan c, beyitler i, süer k, çakır n, SAYAN M, ŞANLIDAĞ T (2022). The pediatric asymptomatic SARS-CoV-2 IgG seropositivity in the Turkish Republic of Northern Cyprus. Turkish Journal of Pediatrics, 64(1), 179 - 185. 10.24953/turkjped.2021.1330 |
| Chicago | Gazi Umut,ARIKAN AYSE,Ruh Emrah,sanlidag burcin,dalkan ceyhun,beyitler ilke,süer kaya,çakır nedim,SAYAN MURAT,ŞANLIDAĞ Tamer The pediatric asymptomatic SARS-CoV-2 IgG seropositivity in the Turkish Republic of Northern Cyprus. Turkish Journal of Pediatrics 64, no.1 (2022): 179 - 185. 10.24953/turkjped.2021.1330 |
| MLA | Gazi Umut,ARIKAN AYSE,Ruh Emrah,sanlidag burcin,dalkan ceyhun,beyitler ilke,süer kaya,çakır nedim,SAYAN MURAT,ŞANLIDAĞ Tamer The pediatric asymptomatic SARS-CoV-2 IgG seropositivity in the Turkish Republic of Northern Cyprus. Turkish Journal of Pediatrics, vol.64, no.1, 2022, ss.179 - 185. 10.24953/turkjped.2021.1330 |
| AMA | Gazi U,ARIKAN A,Ruh E,sanlidag b,dalkan c,beyitler i,süer k,çakır n,SAYAN M,ŞANLIDAĞ T The pediatric asymptomatic SARS-CoV-2 IgG seropositivity in the Turkish Republic of Northern Cyprus. Turkish Journal of Pediatrics. 2022; 64(1): 179 - 185. 10.24953/turkjped.2021.1330 |
| Vancouver | Gazi U,ARIKAN A,Ruh E,sanlidag b,dalkan c,beyitler i,süer k,çakır n,SAYAN M,ŞANLIDAĞ T The pediatric asymptomatic SARS-CoV-2 IgG seropositivity in the Turkish Republic of Northern Cyprus. Turkish Journal of Pediatrics. 2022; 64(1): 179 - 185. 10.24953/turkjped.2021.1330 |
| IEEE | Gazi U,ARIKAN A,Ruh E,sanlidag b,dalkan c,beyitler i,süer k,çakır n,SAYAN M,ŞANLIDAĞ T "The pediatric asymptomatic SARS-CoV-2 IgG seropositivity in the Turkish Republic of Northern Cyprus." Turkish Journal of Pediatrics, 64, ss.179 - 185, 2022. 10.24953/turkjped.2021.1330 |
| ISNAD | Gazi, Umut vd. "The pediatric asymptomatic SARS-CoV-2 IgG seropositivity in the Turkish Republic of Northern Cyprus". Turkish Journal of Pediatrics 64/1 (2022), 179-185. https://doi.org/10.24953/turkjped.2021.1330 |
